1. Home
  2. GBIO vs WW Comparison

GBIO vs WW Comparison

Compare GBIO & WW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • WW
  • Stock Information
  • Founded
  • GBIO 2016
  • WW 1961
  • Country
  • GBIO United States
  • WW United States
  • Employees
  • GBIO N/A
  • WW N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • WW Other Consumer Services
  • Sector
  • GBIO Health Care
  • WW Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • WW Nasdaq
  • Market Cap
  • GBIO 64.8M
  • WW 75.9M
  • IPO Year
  • GBIO 2020
  • WW 2001
  • Fundamental
  • Price
  • GBIO $0.78
  • WW $0.92
  • Analyst Decision
  • GBIO Strong Buy
  • WW Buy
  • Analyst Count
  • GBIO 2
  • WW 5
  • Target Price
  • GBIO $6.50
  • WW $3.44
  • AVG Volume (30 Days)
  • GBIO 649.2K
  • WW 2.8M
  • Earning Date
  • GBIO 03-05-2025
  • WW 02-26-2025
  • Dividend Yield
  • GBIO N/A
  • WW N/A
  • EPS Growth
  • GBIO N/A
  • WW N/A
  • EPS
  • GBIO N/A
  • WW N/A
  • Revenue
  • GBIO $18,582,000.00
  • WW $807,465,000.00
  • Revenue This Year
  • GBIO $212.74
  • WW N/A
  • Revenue Next Year
  • GBIO N/A
  • WW N/A
  • P/E Ratio
  • GBIO N/A
  • WW N/A
  • Revenue Growth
  • GBIO 514.08
  • WW N/A
  • 52 Week Low
  • GBIO $0.72
  • WW $0.67
  • 52 Week High
  • GBIO $4.65
  • WW $5.22
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 29.26
  • WW 39.73
  • Support Level
  • GBIO $0.72
  • WW $1.03
  • Resistance Level
  • GBIO $1.00
  • WW $1.19
  • Average True Range (ATR)
  • GBIO 0.07
  • WW 0.09
  • MACD
  • GBIO -0.00
  • WW -0.02
  • Stochastic Oscillator
  • GBIO 18.68
  • WW 2.94

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About WW WW International Inc.

WW International Inc is a provider of weight loss solutions. The firm offers its members access to in person workshops and digital solutions as a part of its weight loss and weight management programs. Its digital app provides members access to tools such as, trackers for food, water, activity, weight, content regarding behavioral techniques for building healthy habits and other related tools. Along with its in person workshops and digital solutions, the company also provides members who medically qualify access to clinicians who can prescribe weight management medications when clinically appropriate. The company generates majority of its revenue in the form of Subscription Revenue. Geographically, the company generates key revenue from North America and rest from International markets.

Share on Social Networks: